Barriers to typhoid fever vaccine access in endemic countries
M Imran Khan,1 Carlos Franco-Paredes,2,3 Sushant Sahastrabuddhe,4 R Leon Ochiai,5 Vittal Mogasale,4 Bradford D Gessner6 1Center of Excellence in Women and Child Health, The Aga Khan University, Karachi, Pakistan; 2Hospital Infantil de México, Federico Gómez, México DF., Mexico; 3Phoebe Putney Memori...
Main Authors: | , , , , , |
---|---|
Format: | Article in Journal/Newspaper |
Language: | English |
Published: |
Dove Medical Press
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/52f6043d51624afd8581a1d6c5d53b57 |
_version_ | 1821839262072438784 |
---|---|
author | Khan MI Franco-Paredes C Sahastrabuddhe S Ochiai RL Mogasale V BD Gessner |
author_facet | Khan MI Franco-Paredes C Sahastrabuddhe S Ochiai RL Mogasale V BD Gessner |
author_sort | Khan MI |
collection | Directory of Open Access Journals: DOAJ Articles |
description | M Imran Khan,1 Carlos Franco-Paredes,2,3 Sushant Sahastrabuddhe,4 R Leon Ochiai,5 Vittal Mogasale,4 Bradford D Gessner6 1Center of Excellence in Women and Child Health, The Aga Khan University, Karachi, Pakistan; 2Hospital Infantil de México, Federico Gómez, México DF., Mexico; 3Phoebe Putney Memorial Hospital, Albany, GA, USA; 4International Vaccine Institute, Seoul, Republic of Korea; 5Sanofi Pasteur, Lyon, 6Agence de Médecine Preventive, Ferney-Voltaire, France Abstract: Typhoid vaccines have been available as a means of disease control and prevention since 1896; however, their use as a routine tool for disease prevention in endemic settings has been hampered because of: 1) insufficient data on disease burden particularly regarding the lack of health care access in the poorest communities affected by typhoid; 2) limitations of the typhoid vaccine, such as shorter duration of protection, moderate efficacy in young children, and no efficacy for infants; 3) inadequate evidence on potential economic benefits when used for a larger population; 4) neglect in favor of alternative interventions that require massive infrastructure; 5) no financial support or commitment regarding vaccine delivery cost; 6) ambivalence about whether to invest in water and sanitation hygiene versus the vaccine; and 7) clarity on global policy for country adoption. If current typhoid-protein conjugate vaccines live up to their promise of higher efficacy, longer duration of protection, and efficacy in young children, typhoid vaccine use will be a critical component of short- and medium-term disease control strategies. Typhoid control could be accelerated if the global framework includes plans for accelerated introduction of the conjugate typhoid vaccine in developing countries. Keywords: typhoid fever, vaccines, policy, endemic countries, barriers, immunization |
format | Article in Journal/Newspaper |
genre | Arctic |
genre_facet | Arctic |
geographic | Arctic Pasteur |
geographic_facet | Arctic Pasteur |
id | ftdoajarticles:oai:doaj.org/article:52f6043d51624afd8581a1d6c5d53b57 |
institution | Open Polar |
language | English |
long_lat | ENVELOPE(140.099,140.099,-66.625,-66.625) |
op_collection_id | ftdoajarticles |
op_relation | https://www.dovepress.com/barriers-to-typhoid-fever-vaccine-access-in-endemic-countries-peer-reviewed-article-RRTM https://doaj.org/toc/1179-7282 1179-7282 https://doaj.org/article/52f6043d51624afd8581a1d6c5d53b57 |
op_source | Research and Reports in Tropical Medicine, Vol Volume 8, Pp 37-44 (2017) |
publishDate | 2017 |
publisher | Dove Medical Press |
record_format | openpolar |
spelling | ftdoajarticles:oai:doaj.org/article:52f6043d51624afd8581a1d6c5d53b57 2025-01-16T20:44:21+00:00 Barriers to typhoid fever vaccine access in endemic countries Khan MI Franco-Paredes C Sahastrabuddhe S Ochiai RL Mogasale V BD Gessner 2017-03-01T00:00:00Z https://doaj.org/article/52f6043d51624afd8581a1d6c5d53b57 EN eng Dove Medical Press https://www.dovepress.com/barriers-to-typhoid-fever-vaccine-access-in-endemic-countries-peer-reviewed-article-RRTM https://doaj.org/toc/1179-7282 1179-7282 https://doaj.org/article/52f6043d51624afd8581a1d6c5d53b57 Research and Reports in Tropical Medicine, Vol Volume 8, Pp 37-44 (2017) typhoid fever vaccines policy endemic countries barriers immunization Arctic medicine. Tropical medicine RC955-962 article 2017 ftdoajarticles 2022-12-31T03:46:54Z M Imran Khan,1 Carlos Franco-Paredes,2,3 Sushant Sahastrabuddhe,4 R Leon Ochiai,5 Vittal Mogasale,4 Bradford D Gessner6 1Center of Excellence in Women and Child Health, The Aga Khan University, Karachi, Pakistan; 2Hospital Infantil de México, Federico Gómez, México DF., Mexico; 3Phoebe Putney Memorial Hospital, Albany, GA, USA; 4International Vaccine Institute, Seoul, Republic of Korea; 5Sanofi Pasteur, Lyon, 6Agence de Médecine Preventive, Ferney-Voltaire, France Abstract: Typhoid vaccines have been available as a means of disease control and prevention since 1896; however, their use as a routine tool for disease prevention in endemic settings has been hampered because of: 1) insufficient data on disease burden particularly regarding the lack of health care access in the poorest communities affected by typhoid; 2) limitations of the typhoid vaccine, such as shorter duration of protection, moderate efficacy in young children, and no efficacy for infants; 3) inadequate evidence on potential economic benefits when used for a larger population; 4) neglect in favor of alternative interventions that require massive infrastructure; 5) no financial support or commitment regarding vaccine delivery cost; 6) ambivalence about whether to invest in water and sanitation hygiene versus the vaccine; and 7) clarity on global policy for country adoption. If current typhoid-protein conjugate vaccines live up to their promise of higher efficacy, longer duration of protection, and efficacy in young children, typhoid vaccine use will be a critical component of short- and medium-term disease control strategies. Typhoid control could be accelerated if the global framework includes plans for accelerated introduction of the conjugate typhoid vaccine in developing countries. Keywords: typhoid fever, vaccines, policy, endemic countries, barriers, immunization Article in Journal/Newspaper Arctic Directory of Open Access Journals: DOAJ Articles Arctic Pasteur ENVELOPE(140.099,140.099,-66.625,-66.625) |
spellingShingle | typhoid fever vaccines policy endemic countries barriers immunization Arctic medicine. Tropical medicine RC955-962 Khan MI Franco-Paredes C Sahastrabuddhe S Ochiai RL Mogasale V BD Gessner Barriers to typhoid fever vaccine access in endemic countries |
title | Barriers to typhoid fever vaccine access in endemic countries |
title_full | Barriers to typhoid fever vaccine access in endemic countries |
title_fullStr | Barriers to typhoid fever vaccine access in endemic countries |
title_full_unstemmed | Barriers to typhoid fever vaccine access in endemic countries |
title_short | Barriers to typhoid fever vaccine access in endemic countries |
title_sort | barriers to typhoid fever vaccine access in endemic countries |
topic | typhoid fever vaccines policy endemic countries barriers immunization Arctic medicine. Tropical medicine RC955-962 |
topic_facet | typhoid fever vaccines policy endemic countries barriers immunization Arctic medicine. Tropical medicine RC955-962 |
url | https://doaj.org/article/52f6043d51624afd8581a1d6c5d53b57 |